Paget's disease of bone: Clinical, pathogenetic and therapeutic aspects
- 1 April 1997
- journal article
- review article
- Published by Elsevier BV in Bailliere's Clinical Endocrinology and Metabolism
- Vol. 11 (1), 117-143
- https://doi.org/10.1016/s0950-351x(97)80553-8
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Adverse Effects of BisphosphonatesDrug Safety, 1996
- A multicenter trial of low dose gallium nitrate in patients with advanced Paget's disease of boneJournal of Clinical Endocrinology & Metabolism, 1995
- Evaluation of the efficacy and safety of oral tiludronate in paget's disease of boneArthritis & Rheumatism, 1992
- Parathyroid hormone (PTH) and PTH-like protein (PLP) stimulate interleukin-6 production by osteogenic cells: A possible role of interleukin-6 in osteoclastogenesisBiochemical and Biophysical Research Communications, 1989
- Efficacious Management with Aminobisphosphonate (APD) in Paget??s Disease of BoneClinical Orthopaedics and Related Research, 1987
- Skeletal Distribution and Biochemical Parameters of Paget??s DiseaseClinical Orthopaedics and Related Research, 1987
- Quantitative bone scintigraphy in Paget's disease treated with APDThe British Journal of Radiology, 1985
- PATHOLOGIC FRACTURE DUE TO SEVERE OSTEOMALACIA FOLLOWING LOW‐DOSE DIPHOSPHONATE TREATMENT OF PAGET'S DISEASE OF BONEAustralian and New Zealand Journal of Medicine, 1983
- Clinical and biochemical effects of EHDP in Paget's disease of bone: Patterns of response to initial treatment and to long-term therapyMetabolic Bone Disease and Related Research, 1981
- Paget's disease of bone and hyperparathyroidism: Coincidence or causal relationship?Calcified Tissue International, 1978